ATH
Click for more information
0.00% 0.3¢ alterity therapeutics limited

Huntington disease trial completed. Results in October

  1. Shareshares
    64 Posts.
    clock Created with Sketch.
    23/07/13
    10:41
    Post #: 12097572
    Huntington disease trial completed. Results in October
    PBT Price at posting: 27.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS HotCopper users bullish on Raiden's news it won Andover South approval as expected
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week
right-arrow Created with Sketch.
NEWS The psychology of spending: How to manage finances wisely
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.631K 1.210M

Buyers (Bids)

No. Vol. Price($)
60 81072032 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 2447647 3
View Market Depth
Last trade - 15.59pm 18/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.